Portfolio addition: Unicycive Therapeutics Inc. (UNCY)

Have been doing a stock research over the past 2 days and went through at least a 100 stocks. Finding awesome stocks takes time. Spent the most time yesterday researching TEVA (Teva Pharmaceutical Industries). Really like what the new CEO is doing and how he is steering the company to achieve higher Operating Income margin, but there is too much debt. Also, the company expects to grow at about 5% in the next few years. So, after spending 2 hours of research, I discarded the idea.

Instead, I found Unicycive Therapeutics Inc. (UNCY). This one is a wild bet, so I invested a little.

Its market cap is only $72.38M. Currently, it trades at $0.585. I know some of you will think I am crazy investing into a company with a market capitalization of $72 million and no revenues. But, as I said it is a wild bet. So it may go up a lot or may go to zero.

The company has developed a drug Oxylanthanum Carbonate (OLC), for the treatment of hyperphosphatemia in patients with chronic kidney disease. It has NDA under review with June 28, 2025 PDUFA date under 505(b)(2) regulatory pathway.

505(b)(2) is a streamlined approval process for a new drug application (NDA) that allows applicants to rely on data from publicly available studies or studies conducted by others for previously approved drugs. This pathway is often used for new formulations, routes of administration, or indications of known chemical entities, potentially leading to faster approval times and lower development costs compared to traditional NDAs. 

Analysts are very bullish on the stock with 7 buy ratings and a target price of $6.

Source: MarketWatch

The reason for high ratings are the expected revenues and earnings once/if the drug is approved:

The earnings are expected to realize is strong EPS:

Taking the average expected EPS of $1.8 at the end of 2027 and a PE of 20 gives us $36 price target. I know, sounds crazy with the current price of $0.585.

There is really no more analysis that we can do. It is just a bet with either increasing you money x times vs. going to zero. I could have hidden this trade, but I want to be transparent with my portfolio.

You can see my portfolio live here: wininstocks.com/watch-list-and-portfolio

I have just started rebuilding it, so there are not too many entries, but I plan to continue to build it with you watching me.

---

Disclaimer: As usual, trade at your own risk. I own UNCY stock. I do not suggest you should buy any of the stocks I write about. As usual, please do your own due diligence before investing your own money in any of the stocks I write about. The above analysis is quite basic and just gives ideas for further research. A much deeper analysis is required for each stock, including the analysis of operations, debt, etc. I may sell any of the stocks I say I currently own at any moment before it reaches the targets that I set or keep them for even when they reach the target.